Overall, we have demonstrated that although levels of GLI3 are enhanced in models of ARPKD, dampening this upregulation does not alter cyst progression or spheroid size in mouse and human models respectively, highlighting the functional complexity of the Hh pathway in ARPKD. This evidence concerns the gene GLI3 and autosomal recessive polycystic kidney disease.